[Prophylactic controlled trials with cotrimoxazole in afebrile neutropenic patients with malignant hemopathies].
D000328:Adult; D000380:Agranulocytosis / Q000150:complications*; D002648:Child; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D005334:Fever / Q000150:complications / Q000517:prevention & control*; D006801:Humans; D017053:Infection Control; D007239:Infections / Q000150:complications; D007938:Leukemia / Q000150:complications*; D008223:Lymphoma / Q000150:complications*; D009503:Neutropenia / Q000150:complications*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole
Estudios controlados de profilaxis con cotrimoxasol en pacientes neutropénicos afebriles con hemopatías malignas.